热门资讯> 正文

Tandem糖尿病护理2024年第三季度盈利预览

2024-11-06 06:20

Tandem Diabetes Care (NASDAQ:TNDM) is scheduled to announce Q3 earnings results on Wednesday, November 6th, after market close.
The consensus EPS Estimate is -$0.41 and the consensus Revenue Estimate is $223.6M (+20.5% Y/Y).
Over the last 3 months, EPS estimates have seen 0 upward revisions and 12 downward. Revenue estimates have seen 12 upward revisions and 1 downward.

More on Tandem Diabetes Care

Tandem Diabetes: Mobi's Surprise Sales Fail To Offset Flat Operating Margin
BDX upped to buy by Citi, TNDM put on Negative Catalyst Watch
Tandem Diabetes rises as insulin pump cleared for use in EU with Lilly insulin
Seeking Alpha’s Quant Rating on Tandem Diabetes Care
Historical earnings data for Tandem Diabetes Care

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。